During the course of the forecast period, regulatory authorities are anticipated to approve more products and grant licences to important market players. For instance, the debut of a new rosacea treatment was announced by the medical technology company Kleresca in August 2018. Based on the innovative and patented bio photonic technology developed by Kleresca, it stimulates the skin's natural repair processes through photobiomodulation by using fluorescent light energy. Market growth is anticipated to be fuelled throughout the forecast period by an increase in inorganic strategy, such as partnerships, by leading industry players. Asphericon, a company that offers customised optical services, for instance, announced in September 2020 a partnership with OptoSigma, a company that makes optical and opto-mechanical products, to sell aspheric optics through OptoSigma's websites and sales channels in the European, North American, and South American markets. On November 24, 2020, Jenoptik Light, a global company that develops optical technologies, and Optics BioPhotonics Group, a company that specialises in providing technological solutions in biophonotics, announced a partnership to provide a next-generation automated microscope for inline cellular analysis as well as microscopy, illumination systems, and high-performing image sensors.
According to Coherent Market Insights, The global Biophotonics Market is anticipated to reach US$ 67,324.7 million in 2022 and grow at a CAGR of 8.7% during the following five years (2022-2030).
Key Companies in the Biophotonics Industry:
1. Becton, Dickinson & Co
The company was established in 1897 and has its headquarters in New Jersey, U.S. The business produces and markets reagents, instrument systems, and medical equipment. Moreover, BD offers analytics and consulting services in some areas. BD receives FDA 510(k) clearance in March 2023 for the first-ever high-throughput diagnostic test for infectious vaginitis. BD will launch a High-Throughput Single-Cell Multiomics Platform in February 2023 to broaden the scope of scientific discovery.
2. Affymetrix Inc.
The firm was founded in 1992 and its main office is in California, United States. Life science apparatus is provided by Affymetrix, Inc. The business provides goods, equipment, and assets for basic research, industrial application, and plant and animal genomes and transcriptomics. In the present, Affymetrix develops and offers cutting-edge technologies that enable multiplex and parallel study of biological systems at the cell level.
